Evaluation of the safety and efficacy of gastric contractility modulation (GCM) stimulation
using the TANTALUS System in the improvement of glycemic control measured by changes in
HbA1c. Effects of GCM on weight loss and associated co-morbid conditions will also be
evaluated
Clinical Trial Conditions: Diabetes Mellitus, Type 2
Treatments in this Clinical Trial : Tantalus System, TANTALUS system
Eligible Clinical Trial Participant Age : Between 18 years to 70 years
Can Healthy Volunteers Participate: No
Clinical Trial Lead Sponsor: MetaCure (USA), Inc.
Detailed Clinical Trial Description: Evaluation of the safety and efficacy of gastric contractility modulation (GCM) stimulation
using the TANTALUS System in the improvement of glycemic control measured by changes in
HbA1c. Effects of GCM on weight loss and associated co-morbid conditions will also be
evaluated
The clinical trial information was obtained from http://clinicaltrials.gov/ct2/show/NCT01303302
Related posts:
- Study of AC-201 in Patients With Type 2 Diabetes Mellitus
- Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE – Diabetes
- Effect of Bariatric Surgery on Mechanisms of Type 2 Diabetes
- Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes
- Weight Loss studies in Milwaukee, Wisconsin (WI)
